Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Inogen Inc (INGN) until September 11, 2023. Inogen Inc reported in an 8-K filed September 7, 2023 that Kristin Caltrider resigned as Executive Vice President, Finance, Chief Financial Officer and Treasurer, effective September 11, 2023. The proxy statement of Inogen Inc reports total compensation of $1,238,671 for Kristin Caltrider in fiscal 2023, including a base salary of $355,526. Disclosed compensation is on record for 2 fiscal years. Kristin Caltrider has spoken on 6 earnings calls across 1 company, most recently for Inogen Inc on July 13, 2023. The companies whose calls Kristin Caltrider spoke on are classified in the Healthcare sector.
“On September 1, 2023, Kristin Caltrider, Executive Vice President, Finance, Chief Financial Officer and Treasurer, notified Inogen, Inc. (the “Company”) of her intention to step down as an officer of the Company effective upon the date a new Executive Vice President, Chief Financial Officer and Treasurer commences employment, which will occur on September 11, 2023.”
“Unless otherwise noted, all financial comparisons are to the prior year comparable period. Total revenue for the second quarter of 2023 was $83.6 million, a decrease of 19.1% versus the prior period.”
“Total revenue for the first quarter of 2023 was $72.2 million, in line with our internal expectations. Revenues decreased 10.2% year-over-year from the first quarter of 2022.”
“Total revenue for the fourth quarter of 2022 was $88.1 million, 15.3% year-over-year growth from the fourth quarter of 2021. The increase was driven primarily by higher U.S. business sales and rental revenues, partially offset by lower direct-to-consumer sales.”
“For the third quarter, foreign exchange had a negative 130 basis points impact on total revenue and a negative 550 basis points impact on international revenue.”
“Total revenue for the second quarter of 2022 was $103.4 million, a substantial sequential increase of approximately 29% from the first quarter of 2022. This improvement was made possible by higher production volumes available for sale in the quarter.”
Start not stated–2023-09-11
INGN
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $355,526 | $1,238,671 |
| 2022 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $346,923 | $2,216,462 |
